FDA Investigator Amy M Codella
Amy M Codella has conducted inspections on 14 sites in 1 countries as of 01 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
01 May 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Amy M Codella:
Addam S Reynolds,
Adetutu M Gidado,
Alberto A Viciedo,
Althea A Williams,
Amy L Singer,
Amy M Cramer,
Anita R Michael,
Annemarie B Randow,
Annemarie Bodnar,
Barbara Jwilimczyk Macri,
Byungja E Marciante,
Cary Greene,
Charles J Chacko,
Daniel J Grabicki,
Dawn L Wydner,
Dhaval H Patel,
Dolores Harper,
Doreen P Gubbay,
Dorothy J Denes,
Douglas C Kovacs,
Edward O'shaughnessy,
Emest F Bizjak,
Eric Rothschild,
Erin D Mccaffery,
Fred Razzaghi,
Frederick F Razzaghi,
Gianine E Delade,
Helen B Ricalde,
Helen Verdel,
James R Birkenstamm,
Jason M Sluzynski,
Jean M Kelahan,
Jessica M Monteiro,
Jill M Sooter,
Jill Mielziner,
Johnna L Bleem,
Jose M Cayuela,
Josh Renzo N Ramilo,
Joy Rkozlowski Klena,
K Gonzlez,
Karen E D'orazio,
Karishma G Gopaul,
Keith M Reilly,
Kelli F Dobilas,
Kelli F Regenye,
Kendra L Brooks,
Kerry A Kurdilla,
Kinh Q Mac,
Kristy A Zielny,
L Zam Lam,
Laishan L Lam,
Larry Johnson,
Laura Fontan, MS,
Lawrence R Johnson,
Li Li,
Lisa B Hall,
Marcellinus D Dordunoo,
Marcelo O Mangalindan, Jr,
Maria Estrella,
Mayar M Mussa,
Melissa B Libby,
Meyer J Slobotsky,
Michael R Klapal,
Michael Serrano,
Msdap Gonzlezk,
Nancy L Rolli,
Nicholas A Violand,
Paul L Bellamy,
Peter R Lenahan,
Raymond L Cheung,
Regina T Brown,
Robert G Ruff,
Rodrigo Vilchez,
Russell J Glapion,
Samir C Gala,
Sarah Forney,
Schultz,
Sherri J Liu,
Sinai I Davis,
Stephanie T Durso,
Stephen J Mottola,
Stephenie M Ortiz,
Suchan Kim,
Susan M Halsted,
Tamil Arasu, PhD,
Tara G Bizjak,
Tara R Gooen,
Unnee Ranjan,
Valerie C Reed,
Victoria Spivak,
Whitney S Reynolds,
William R Chang,
Yvesna C Blaise,
Yvins Dezan,
Zakaria I Ganiyu
Amy M Codella's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more